Get started
AMGEN INC. DL-,0001AMGEN INC. DL-,0001AMGEN INC. DL-,0001

AMGEN INC. DL-,0001

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

AMG chart


Full chart

Key facts today

Amgen anticipates Phase 2 trial results for its weight-loss drug MariTide by year-end. Analysts forecast significant weight loss, but concerns over side effects may affect investor interest.
Analyze the impactAnalyze the impact

AMG upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪142.06 B‬ EUR
Dividend yield (indicated)
3.21%
Price to earnings Ratio (TTM)
35.95
Basic EPS (TTM)
7.10 EUR
Net income (FY)
‪6.09 B‬ EUR
Revenue (FY)
‪25.38 B‬ EUR
Shares float
‪536.14 M‬
Beta (1Y)
0.62

Employees


Employees (FY)
‪26.7 K‬
Change (1Y)
‪+1.5 K‬ +5.95%
Revenue / Employee (1Y)
‪1.05 M‬ EUR
Net income / Employee (1Y)
‪251.57 K‬ EUR

About Amgen Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Robert A. Bradway
Website
amgen.com
Headquarters
Thousand Oaks
Founded
1980
FIGI
BBG000DJ1P97
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

AMG news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

AMG highest yielding bonds


AMGN5186584
Amgen Inc. 2.77% 01-SEP-2053
Yield to maturity
6.94%
Maturity date
Sep 1, 2053
AMGN5235280
Amgen Inc. 3.0% 15-JAN-2052
Yield to maturity
6.47%
Maturity date
Jan 15, 2052
US31162CS7
AMGEN 20/50
Yield to maturity
6.46%
Maturity date
Feb 21, 2050
US31162CR9
AMGEN 20/40
Yield to maturity
6.33%
Maturity date
Feb 21, 2040
AMGN5235282
Amgen Inc. 2.8% 15-AUG-2041
Yield to maturity
6.30%
Maturity date
Aug 15, 2041
US31162DG2
AMGEN 22/62
Yield to maturity
6.29%
Maturity date
Feb 22, 2062
US31162BP4
AMGEN 12/43
Yield to maturity
6.27%
Maturity date
May 15, 2043
AMGD
AMGEN 22/52
Yield to maturity
6.26%
Maturity date
Feb 22, 2052
US31162BZ2
AMGEN 15/45
Yield to maturity
6.18%
Maturity date
May 1, 2045
US31162DK3
AMGEN 22/53
Yield to maturity
6.07%
Maturity date
Mar 1, 2053
AMGN4437315
Amgen Inc. 4.563% 15-JUN-2048
Yield to maturity
6.06%
Maturity date
Jun 15, 2048

Explore more bonds 

Sparks


Curated watchlists where AMG is featured.

See all sparks 

Frequently Asked Questions


The current price of AMG is 274.00 EUR — it has increased by 0.72% in the past 24 hours. Watch AMGEN INC. DL-,0001 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange AMGEN INC. DL-,0001 stocks are traded under the ticker AMG.
AMG stock has fallen by −3.47% compared to the previous week, the month change is a −5.69% fall, over the last year AMGEN INC. DL-,0001 has showed a 13.88% increase.
We've gathered analysts' opinions on AMGEN INC. DL-,0001 future price: according to them, AMG price has a max estimate of 383.47 EUR and a min estimate of 189.37 EUR. Watch AMG chart and read a more detailed AMGEN INC. DL-,0001 stock forecast: see what analysts think of AMGEN INC. DL-,0001 and suggest that you do with its stocks.
AMG reached its all-time high on Aug 5, 2024 with the price of 319.00 EUR, and its all-time low was 25.35 EUR and was reached on Mar 20, 2008. View more price dynamics on AMG chart.
See other stocks reaching their highest and lowest prices.
AMG stock is 0.60% volatile and has beta coefficient of 0.62. Track AMGEN INC. DL-,0001 stock price on the chart and check out the list of the most volatile stocks — is AMGEN INC. DL-,0001 there?
Today AMGEN INC. DL-,0001 has the market capitalization of ‪142.73 B‬, it has decreased by −6.21% over the last week.
Yes, you can track AMGEN INC. DL-,0001 financials in yearly and quarterly reports right on TradingView.
AMGEN INC. DL-,0001 is going to release the next earnings report on Feb 4, 2025. Keep track of upcoming events with our Earnings Calendar.
AMG earnings for the last quarter are 5.01 EUR per share, whereas the estimation was 4.74 EUR resulting in a 5.79% surprise. The estimated earnings for the next quarter are 4.78 EUR per share. See more details about AMGEN INC. DL-,0001 earnings.
AMGEN INC. DL-,0001 revenue for the last quarter amounts to ‪7.64 B‬ EUR, despite the estimated figure of ‪7.63 B‬ EUR. In the next quarter, revenue is expected to reach ‪8.40 B‬ EUR.
AMG net income for the last quarter is ‪2.54 B‬ EUR, while the quarter before that showed ‪696.47 M‬ EUR of net income which accounts for 264.95% change. Track more AMGEN INC. DL-,0001 financial stats to get the full picture.
Yes, AMG dividends are paid quarterly. The last dividend per share was 2.12 EUR. As of today, Dividend Yield (TTM)% is 3.17%. Tracking AMGEN INC. DL-,0001 dividends might help you take more informed decisions.
AMGEN INC. DL-,0001 dividend yield was 2.96% in 2023, and payout ratio reached 68.24%. The year before the numbers were 2.95% and 64.07% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 21, 2024, the company has ‪26.70 K‬ employees. See our rating of the largest employees — is AMGEN INC. DL-,0001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AMGEN INC. DL-,0001 EBITDA is ‪10.85 B‬ EUR, and current EBITDA margin is 44.11%. See more stats in AMGEN INC. DL-,0001 financial statements.
Like other stocks, AMG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AMGEN INC. DL-,0001 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AMGEN INC. DL-,0001 technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AMGEN INC. DL-,0001 stock shows the buy signal. See more of AMGEN INC. DL-,0001 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.